Implications of genetic variability of Trypanosoma cruzi for the pathogenesis of Chagas disease.
about
Kinases as druggable targets in trypanosomatid protozoan parasitesTranslational challenges of animal models in Chagas disease drug development: a reviewStructural analysis and molecular docking of trypanocidal aryloxy-quinones in trypanothione and glutathione reductases: a comparison with biochemical data.Lineage analysis of circulating Trypanosoma cruzi parasites and their association with clinical forms of Chagas disease in Bolivia.Regional variation in the correlation of antibody and T-cell responses to Trypanosoma cruzi.Killer Cell Immunoglobulin-like Receptors and Their HLA Ligands are Related with the Immunopathology of Chagas Disease.Protective human leucocyte antigen haplotype, HLA-DRB1*01-B*14, against chronic Chagas disease in Bolivia.Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas diseaseNonspecific lymphocytic myocarditis in baboons is associated with Trypanosoma cruzi infection.Molecular mechanisms of host cell invasion by Trypanosoma cruzi.Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.Are Members of the Triatoma brasiliensis (Hemiptera, Reduviidae) Species Complex Able to Alter the Biology and Virulence of a Trypanosoma cruzi Strain?Mast cells in the colon of Trypanosoma cruzi-infected patients: are they involved in the recruitment, survival and/or activation of eosinophils?Repolarization parameters are associated with mortality in chagas disease patients in the United States.Relationships between altitude, triatomine (Triatoma dimidiata) immune response and virulence of Trypanosoma cruzi, the causal agent of Chagas' disease.Genomic assemblies of newly sequenced Trypanosoma cruzi strains reveal new genomic expansion and greater complexity
P2860
Q26786761-7C05759A-3A7E-4321-BEDB-04346A90EB59Q26796451-3AA62DFE-D138-4C6C-97AE-5B43F6100B7BQ31103011-5D21110E-36F5-411A-B8E0-FF5B5BBE3F49Q33587283-CD911A45-6C09-48C5-A420-2017DCD1A6F5Q33719577-B8339B6D-3A79-41E0-80EC-CE7E9B3B3197Q35610533-B952B080-4CB8-4900-82AD-C3D170AD4BEEQ35842360-D0CD858E-2ECC-42BD-9833-231FF5C01C30Q36668496-A6681A27-5AB7-4ABF-A1C9-BE8C54FBB215Q37340045-4B39594F-63E8-4FB2-ACC9-B31EA786A52EQ37769831-4334C11B-EBAF-4C2B-B7D5-82EA4C4C3441Q37821802-4B6B8756-A0F1-405F-990F-F2FDCBA70377Q41201732-8C6D9559-A149-4502-85B2-E9F81E561B32Q41466724-56E287A4-EA39-4043-A03F-C2A1736F77A1Q42737169-B134FCA5-477A-4FE1-97A5-B4AEA48B816CQ47977936-632DD24E-CCA0-4771-8EF2-4648C285CD8EQ57050458-91B8807D-60A5-4F49-96EA-4AD9C7D8C9F0
P2860
Implications of genetic variability of Trypanosoma cruzi for the pathogenesis of Chagas disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Implications of genetic variab ...... athogenesis of Chagas disease.
@en
type
label
Implications of genetic variab ...... athogenesis of Chagas disease.
@en
prefLabel
Implications of genetic variab ...... athogenesis of Chagas disease.
@en
P2860
P1476
Implications of genetic variab ...... athogenesis of Chagas disease.
@en
P2093
Ana Elizabete Silva
Fernanda da Silva Manoel-Caetano
P2860
P304
P356
10.1590/S0102-311X2007001000002
P577
2007-10-01T00:00:00Z